This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

Charles Marwick

JAMA. 2000;284:1501-1502.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Bethesda, Md—New moves are coming to protect human research subjects. Greg Koski, PhD, newly appointed director of the Office of Human Research Protection, has put clinical researchers on notice that if they fail to ensure that participants in their studies are properly protected, they will be put out of business. Since he has just taken on the job, Koski was not able to spell out how this mandate might be implemented, but his intention was clear. (The office he heads was recently transferred from the National Institutes of Health, where it was called the Office for Protection From Research Risks, to the Department of Health and Human Services [DHHS].)

Speaking at a meeting on "Human Subject Protection and Financial Conflict of Interest," held at the National Institutes of Health in August, Koski said, "Research has to be based on the highest standards of responsible conduct, based on . . . [Full Text of this Article]